India Glycols is trading 5.24% down at ₹306.80, with no fresh company-specific announcement clearly explaining the November 4 move.

  • The company previously told exchanges it was unaware of a specific reason for share-price movements and said they appeared market-driven.
  • Materials-sector weakness and falling industrial metals provide broader context but do not establish the direct cause.
  • IGL Spirits and Ennature Bio Pharma began trading November 4 after earlier listing approvals; no source linked those listings to the decline.